Identification of Core Prognosis-Related Candidate Genes in Cervical Cancer Via Integrated Bioinformatical Analysis

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2020 Apr 8

PMID 32258155

Citations 11

Authors

Jianxia Wei

Yang Wang

Kejian Shi

Ying Wang

Affiliations

Soon will be listed here.

Abstract

Purposes: Cervical cancer (CC) is one of the highest frequently occurred malignant gynecological tumors with high rates of morbidity and mortality. Here, we aimed to identify significant genes associated with poor outcome. . Differentially expressed genes (DEGs) between CC tissues and normal cervical tissues were picked out by GEO2R tool and Venn diagram software. Database for Annotation, Visualization and Integrated Discovery (DAVID) was performed to analyze gene ontology (GO) and Kyoto Encyclopedia of Gene and Genome (KEGG) pathway. The protein-protein interactions (PPIs) of these DEGs were visualized by Cytoscape with Search Tool for the Retrieval of Interacting Genes (STRING). Afterwards, Kaplan-Meier analysis was applied to analyze the overall survival among these genes. The Gene Expression Profiling Interactive Analysis (GEPIA) was applied for further validation of the expression level of these genes.

Results: The mRNA expression profile datasets of GSE63514, GSE27678, and GSE6791 were downloaded from the Gene Expression Omnibus database (GEO). In total, 76 CC tissues and 35 normal tissues were collected in the three profile datasets. There were totally 73 consistently expressed genes in the three datasets, including 65 up-regulated genes and 8 down-regulated genes. Of PPI network analyzed by Molecular Complex Detection (MCODE) plug-in, all 65 up-regulated genes and 4 down-regulated genes were selected. The results of the Kaplan-Meier survival analysis showed that 3 of the 65 up-regulated genes had a significantly worse prognosis, while 3 of the 4 down-regulated genes had a significantly better outcome. For validation in GEPIA, 4 of 6 genes (PLOD2, ANLN, AURKA, and AR) were confirmed to be significantly deregulated in CC tissues compared to normal tissues.

Conclusion: We have identified three up-regulated (PLOD2, ANLN, and AURKA) and a down-regulated DEGs (AR) with poor prognosis in CC on the basis of integrated bioinformatical methods, which could be regarded as potential therapeutic targets for CC patients.

Citing Articles

Identification of Crucial Genes and Signaling Pathways in Alectinib-Resistant Lung Adenocarcinoma Using Bioinformatic Analysis.

Li Z, Fan Y, Ma Y, Meng N, Li D, Wang D Mol Biotechnol. 2023; 66(12):3655-3673.

PMID: 38142454 DOI: 10.1007/s12033-023-00973-y.

Network-based drug repurposing for HPV-associated cervical cancer.

Ahmed F, Yang Y, Samantasinghar A, Kim Y, Ko J, Choi K Comput Struct Biotechnol J. 2023; 21:5186-5200.

PMID: 37920815 PMC: 10618120. DOI: 10.1016/j.csbj.2023.10.038.

Identification of Novel Genes and Associated Drugs in Cervical Cancer by Bioinformatics Methods.

Wang D, Liu Y, Cheng S, Liu G Med Sci Monit. 2022; 28:e934799.

PMID: 35428744 PMC: 9020271. DOI: 10.12659/MSM.934799.

Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.

Reza M, Harun-Or-Roshid M, Islam M, Hossen M, Hossain M, Feng S Int J Mol Sci. 2022; 23(7).

PMID: 35409328 PMC: 8999699. DOI: 10.3390/ijms23073968.

Identification of Key Pathways and Establishment of a Seven-Gene Prognostic Signature in Cervical Cancer.

An R, Meng S, Qian H J Oncol. 2022; 2022:4748796.

PMID: 35154316 PMC: 8837458. DOI: 10.1155/2022/4748796.

References

Liu Q, Zhang X, Tang H, Liu J, Fu C, Sun M . Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma. Pathol Oncol Res. 2019; 26(3):1583-1594. DOI: 10.1007/s12253-019-00740-y. View

Dai F, Chen G, Wang Y, Zhang L, Long Y, Yuan M . Identification of candidate biomarkers correlated with the diagnosis and prognosis of cervical cancer via integrated bioinformatics analysis. Onco Targets Ther. 2019; 12:4517-4532. PMC: 6581759. DOI: 10.2147/OTT.S199615. View

Song Y, Tan J, Gao X, Wang L . Integrated analysis reveals key genes with prognostic value in lung adenocarcinoma. Cancer Manag Res. 2018; 10:6097-6108. PMC: 6252781. DOI: 10.2147/CMAR.S168636. View

Zhou W, Wang Z, Shen N, Pi W, Jiang W, Huang J . Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer. Mol Cell Biochem. 2014; 398(1-2):11-9. DOI: 10.1007/s11010-014-2200-6. View

Noel J, Bucella D, Fayt I, Simonart T, Buxant F, Anaf V . Androgen receptor expression in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix. Int J Gynecol Pathol. 2008; 27(3):437-41. DOI: 10.1097/PGP.0b013e318160c599. View

Di J, Rutherford S, Chu C . Review of the Cervical Cancer Burden and Population-Based Cervical Cancer Screening in China. Asian Pac J Cancer Prev. 2015; 16(17):7401-7. DOI: 10.7314/apjcp.2015.16.17.7401. View

Harima Y, Sawada S, Nagata K, Sougawa M, Ostapenko V, Ohnishi T . Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy. Int J Oncol. 2001; 18(3):493-7. DOI: 10.3892/ijo.18.3.493. View

Wong Y, Rogers M, Cheung T, Yim S, Chang A . C-myc mutation detected by polymerase chain reaction--heteroduplex in cervical cancer. Gynecol Obstet Invest. 1997; 44(2):136-40. DOI: 10.1159/000291505. View

Lee D . High androgen receptor levels are predictive of decreased survival in prostate cancer. Clin Prostate Cancer. 2004; 2(1):13-4. DOI: 10.1016/s1540-0352(11)70012-9. View

10.

Sang L, Wang X, Xu D, Zhao W . Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma. World J Gastroenterol. 2018; 24(24):2605-2616. PMC: 6021769. DOI: 10.3748/wjg.v24.i24.2605. View

11.

Hu S, Liao Y, Chen L . Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis. Med Sci Monit. 2018; 24:6438-6448. PMC: 6151107. DOI: 10.12659/MSM.910088. View

12.

Xu J, Zheng H, Yuan S, Zhou B, Zhao W, Pan Y . Overexpression of ANLN in lung adenocarcinoma is associated with metastasis. Thorac Cancer. 2019; 10(8):1702-1709. PMC: 6669805. DOI: 10.1111/1759-7714.13135. View

13.

Duan X, Xu X, Yin B, Hong B, Liu W, Liu Q . The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy. J Clin Lab Anal. 2019; 33(5):e22871. PMC: 6595293. DOI: 10.1002/jcla.22871. View

14.

Zhao X, Cui Y, Jiang S, Liu K, Han H, Liu X . Human telomerase gene and high-risk human papillomavirus infection are related to cervical intraepithelial neoplasia. Asian Pac J Cancer Prev. 2015; 16(2):693-7. DOI: 10.7314/apjcp.2015.16.2.693. View

15.

Erpolat O, Gocun P, Akmansu M, Karakus E, Akyol G . High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer. Strahlenther Onkol. 2012; 188(3):248-54. DOI: 10.1007/s00066-011-0042-7. View

16.

Zeng S, Yu X, Ma C, Song R, Zhang Z, Zi X . Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma. Sci Rep. 2017; 7(1):3151. PMC: 5466664. DOI: 10.1038/s41598-017-02990-9. View

17.

Du H, Pang M, Hou X, Yuan S, Sun L . PLOD2 in cancer research. Biomed Pharmacother. 2017; 90:670-676. DOI: 10.1016/j.biopha.2017.04.023. View

18.

Chopra S, Gupta M, Mathew A, Mahantshetty U, Engineer R, Lavanya G . Locally advanced cervical cancer: A study of 5-year outcomes. Indian J Cancer. 2018; 55(1):45-49. DOI: 10.4103/ijc.IJC_428_17. View

19.

Wei H, Wang X, Chen K, Ling S, Yi C . Analysis of gene mutation associated with tyrosine kinase inhibitor sensitivity of epidermal growth factor receptor in cervical cancer patients. Eur Rev Med Pharmacol Sci. 2018; 22(19):6280-6287. DOI: 10.26355/eurrev_201810_16036. View

20.

Xia L, Su X, Shen J, Meng Q, Yan J, Zhang C . functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis. Cancer Manag Res. 2018; 10:663-670. PMC: 5896649. DOI: 10.2147/CMAR.S162813. View